Literature DB >> 28483826

Cardiovascular Outcome Trials in Patients With Advanced Kidney Disease: Time for Action.

Faiez Zannad1, Patrick Rossignol2.   

Abstract

Entities:  

Keywords:  cardiovascular diseases; cardiovascular outcomes; clinical trial; kidney; renal insufficiency

Mesh：

Year:  2017        PMID： 28483826     DOI： 10.1161/CIRCULATIONAHA.117.027338

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

1.  Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial.

Authors:  Rajiv Agarwal; Andrew E Cramer; Mary Balmes-Fenwick; Arjun D Sinha; Fangqian Ouyang; Wanzhu Tu
Journal:  Am J Nephrol       Date:  2020-07-14       Impact factor: 3.754

2.  The legacy of ISCHEMIA.

Authors:  Umberto Ianni; Francesco Radico; Fabrizio Ricci; Matteo Perfetti; Federico Archilletti; Giulia Renda; Nicola Maddestra; Sabina Gallina; Marco Zimarino
Journal:  Cardiol J       Date:  2020       Impact factor: 2.737

3.  Beta-blockers in heart failure patients with severe chronic kidney disease-time for a randomized controlled trial?

Authors:  Rajiv Agarwal; Patrick Rossignol
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

4.  Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients.

Authors:  Kathrin Weidner; Michael Behnes; Christel Weiß; Christoph Nienaber; Linda Reiser; Armin Bollow; Gabriel Taton; Thomas Reichelt; Dominik Ellguth; Niko Engelke; Jonas Rusnak; Tobias Schupp; Seung-Hyun Kim; Christian Barth; Jorge Hoppner; Muharrem Akin; Kambis Mashayekhi; Martin Borggrefe; Ibrahim Akin
Journal:  Heart Vessels       Date:  2019-05-10       Impact factor: 2.037

5.  International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.

Authors:  Sripal Bangalore; David J Maron; Jerome L Fleg; Sean M O'Brien; Charles A Herzog; Gregg W Stone; Daniel B Mark; John A Spertus; Karen P Alexander; Mandeep S Sidhu; Glenn M Chertow; William E Boden; Judith S Hochman
Journal:  Am Heart J       Date:  2018-08-01       Impact factor: 4.749

6.  Management of Coronary Disease in Patients with Advanced Kidney Disease.

Authors:  Sripal Bangalore; David J Maron; Sean M O'Brien; Jerome L Fleg; Evgeny I Kretov; Carlo Briguori; Upendra Kaul; Harmony R Reynolds; Tomasz Mazurek; Mandeep S Sidhu; Jeffrey S Berger; Roy O Mathew; Olga Bockeria; Samuel Broderick; Radoslaw Pracon; Charles A Herzog; Zhen Huang; Gregg W Stone; William E Boden; Jonathan D Newman; Ziad A Ali; Daniel B Mark; John A Spertus; Karen P Alexander; Bernard R Chaitman; Glenn M Chertow; Judith S Hochman
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

7.  Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.

Authors:  John A Spertus; Philip G Jones; David J Maron; Daniel B Mark; Sean M O'Brien; Jerome L Fleg; Harmony R Reynolds; Gregg W Stone; Mandeep S Sidhu; Bernard R Chaitman; Glenn M Chertow; Judith S Hochman; Sripal Bangalore
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

Review 8.  Intersection Between Chronic Kidney Disease and Cardiovascular Disease.

Authors:  Luke J Laffin; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

9.  Association between baseline LDL-C and prognosis among patients with coronary artery disease and advanced kidney disease.

Authors:  Bo Wang; Shiqun Chen; Jin Liu; Yan Liang; Liangguang Meng; Xiaoming Yan; Haozhang Huang; Guanzhong Chen; Zhidong Huang; Danyuan Xu; Min Li; Jingjing Liang; Shuangxin Liu; Jiyan Chen; Yong Liu; Ning Tan
Journal:  BMC Nephrol       Date:  2021-05-06       Impact factor: 2.388

10.  Optimal treatment strategies for coronary artery disease in patients with advanced kidney disease: a meta-analysis.

Authors:  Jingwen Yong; Jinfan Tian; Xin Zhao; Xueyao Yang; Haoran Xing; Yi He; Xiantao Song
Journal:  Ther Adv Chronic Dis       Date:  2021-07-07       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.